Recent advances in genomics, imaging and biomarkers are translating into the development and use of increasing specific therapeutics — medicines that target individual pathways to modify the course of disease, and are intended for personalized or stratified use in specific patient populations.
On 21 April 2021 Andi Orlowski joined a selection of great speakers for the ‘Precision Medicine: Empowering the Patient‘, hosted by the Digital Health and Care Alliance.
Andi provided a presentation on the role of precision medicine in population health management.